Covestor’s Agios Pharmaceuticals AGIO Stock Holding History

Covestor’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$0	Sell	7 -5	-42%	-$175	﹤0.01%	2292
2026 Q2	$0	Buy	12 +9	+300%	+$273	﹤0.01%	2452
2026 Q1	$0	Sell	3 -38	-93%	-$1.08K	﹤0.01%	2204
2025 Q4	$1K	Sell	41 -23	-36%	-$807	﹤0.01%	1976
2025 Q3	$3K	Buy	64 +61	+2,033%	+$2.29K	﹤0.01%	1872
2025 Q2	$0	Hold	3	–	–	﹤0.01%	2151
2025 Q1	$0	Sell	3 -2	-40%	-$66	﹤0.01%	2160
2024 Q4	$0	Hold	5	–	–	﹤0.01%	2181
2024 Q3	$0	Sell	5 -7	-58%	-$318	﹤0.01%	2156
2024 Q2	$1K	Buy	12 +8	+200%	+$289	﹤0.01%	1910
2024 Q1	$0	Sell	4 -7	-64%	-$187	﹤0.01%	2186
2023 Q4	$0	Buy	11 +2	+22%	+$45	﹤0.01%	2085
2023 Q3	$0	Buy	9 +4	+80%	+$106	﹤0.01%	2051
2023 Q2	$0	Hold	5	–	–	﹤0.01%	2068
2023 Q1	$0	Hold	5	–	–	﹤0.01%	1945
2022 Q4	$0	Sell	5 -2	-29%	-$56	﹤0.01%	1991
2022 Q3	$0	Buy	+7	New	+$188	﹤0.01%	1916

Other funds holding AGIO

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SCS Capital Management Boston, Massachusetts $11.2B AUM 12.39% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

Covestor's AGIO Position: Q3 2026 in Review

Covestor reduced its Agios Pharmaceuticals (AGIO) stake by 42% in Q3 2026, selling an estimated $175 and leaving 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Covestor first reported a position in AGIO in Q3 2022 and has held it in 17 quarters since. The position peaked at $3K in Q3 2025. 137 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

Covestor held 7 shares of Agios Pharmaceuticals worth $0 as of Q3 2026.
Covestor sold 5 Agios Pharmaceuticals shares in Q3 2026, an estimated $175.
Agios Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2292 holding.
Covestor first reported a position in Agios Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
Covestor's Agios Pharmaceuticals position peaked at $3K in Q3 2025.
137 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.